Your email has been successfully added to our mailing list.

×
0 0.000537188064657837 -0.000341846950236818 -0.00161156419397379 -0.00405332812423701 -0.00102554085071059 -0.0032719636665528 -0.00566489231821066
Stock impact report

They Thought Hemophilia Was a ‘Lifelong Thing.’ They May Be Wrong. [The New York Times]

BioMarin Pharmaceutical Inc. (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
Experimental gene therapies have yielded promising results in early trials. But the drugs have left some patients wary, worried that success will not last. Image A colored scanning electron micrograph of a blood clot. Hemophilia is defined by an inability to form blood clots, leading to uncontrolled bleeds and chronic pain. Credit Steve Gschmeissner/Science Source Aug. 13, 2018 Scientists are edging closer to defeating a longtime enemy of human health: hemophilia, the inability to form blood clots. After trying for decades to develop a gene therapy to treat this disease, researchers are starting to succeed. In recent experiments, brief intravenous infusions of powerful new treatments have rid patients — for now, at least — of a condition that has shadowed them all their lives. There have been setbacks — years of failed clinical trials and dashed hopes. Just last week, a biotech company reported that gene therapy mostly stopped working in two of 12 patients in Show less Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BMRN alerts

from News Quantified
Opt-in for
BMRN alerts

from News Quantified